EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer

被引：0
|
作者：
Soysal, S. D. [1 ]
Muenst, S. [2 ]
Barbie, T. [3 ]
Fleming, T. [3 ]
Gao, F. [4 ]
Spizzo, G. [5 ]
Oertli, D. [1 ]
Viehl, C. T. [1 ]
Obermann, E. C. [2 ]
Gillanders, W. E. [3 ]
机构：
[1] Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland
[3] Washington Univ, Dept Surg, St Louis, MO USA
[4] Washington Univ, Div Biostat, St Louis, MO USA
[5] Franz Tappeiner Hosp, Div Haematol & Oncol, Merano, Italy
来源：
BRITISH JOURNAL OF SURGERY | 2013年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [1] EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer
    Soysal, S. D.
    Muenst, S.
    Barbie, T.
    Fleming, T.
    Gao, F.
    Spizzo, G.
    Oertli, D.
    Viehl, C. T.
    Obermann, E. C.
    Gillanders, W. E.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (07) : 1480 - 1487
  • [2] EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer
    S D Soysal
    S Muenst
    T Barbie
    T Fleming
    F Gao
    G Spizzo
    D Oertli
    C T Viehl
    E C Obermann
    W E Gillanders
    [J]. British Journal of Cancer, 2013, 108 : 1480 - 1487
  • [3] Ezrin is Significantly Overexpressed in Luminal A, Luminal B, and HER2 Subtype Breast Cancer
    Jais, Murni H.
    Zin, Reena R. Md
    Hanapi, Nur A. Muhd
    Ali, Siti A. Md
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (01) : 44 - 48
  • [4] Microvascular proliferation is significantly associated with the HER2 positive, triple negative, and basal-like phenotypes in breast carcinoma
    Aziz, S.
    Wik, E.
    Knutsvik, G.
    Akslen, L.
    [J]. VIRCHOWS ARCHIV, 2016, 469 : S51 - S52
  • [5] In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer
    Katerin Rojas
    Mariona Baliu-Piqué
    Aránzazu Manzano
    Cristina Saiz-Ladera
    Vanesa García-Barberán
    Francisco J. Cimas
    Pedro Pérez-Segura
    Atanasio Pandiella
    Balázs Győrffy
    Alberto Ocana
    [J]. Cellular Oncology, 2021, 44 : 569 - 580
  • [6] Pure salivary duct carcinomas can be classified into luminal, HER2 and basal-like phenotypes
    Di Palma, S.
    Skalova, A.
    Ungari, M.
    Sandison, A.
    Peterse, H.
    Marchio, C.
    Reis-Filho, J. S.
    [J]. LABORATORY INVESTIGATION, 2008, 88 : 234A - 234A
  • [7] Pure salivary duct carcinomas can be classified into luminal, HER2 and basal-like phenotypes
    Di Palma, S.
    Skalova, A.
    Ungari, M.
    Sandison, A.
    Peterse, H.
    Marchio, C.
    Reis-Filho, J. S.
    [J]. MODERN PATHOLOGY, 2008, 21 : 234A - 234A
  • [8] Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype
    Masumi Yanagawa
    Kenzo Ikemot
    Shigeto Kawauchi
    Tomoko Furuya
    Shigeru Yamamoto
    Masaaki Oka
    Atunori Oga
    Yukiko Nagashima
    Kohsuke Sasaki
    [J]. BMC Research Notes, 5 (1)
  • [9] Luminal B breast tumors are not HER2 positive
    Rohit Bhargava
    David J Dabbs
    [J]. Breast Cancer Research, 10
  • [10] Luminal B breast tumors are not HER2 positive
    Bhargava, Rohit
    Dabbs, David J.
    [J]. BREAST CANCER RESEARCH, 2008, 10 (05)
12345